<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231106059970N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-01-28</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>unified protocol versus dyadic-developmental psychotherapy for children and adolescent with PTSD</public_title>
      <acronym></acronym>
      <scientific_title>comparing the of modified version of unified protocol versus dyadic-developmental psychotherapy in reduction of post-traumatic stress symptoms, dissociation, and self-harm in individuals with developmental/post traumatic stress disorder among survivors of the 12-day war</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-01-30</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>62</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/88198</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Study  will employ block randomization at the individual level. Allocation method: true randomization via 4 and 6 variable block size. Random sequence will be generate by random allocation software. Allocation ratio will be 1:1 in each group. Independent researcher will generated the random sequence. Allocation concealment will be ensured using sequentially numbered, opaque, sealed envelopes, Blinding description: In this study, the therapist delivering the interventions, assessors and and data analyzers will be blinded to group allocation. Participants will be aware that there will be two treatment conditions. blinding will be occur after study will be finished.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: Post-traumatic stress disorder. Condition 2: unspecified Post-traumatic stress disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: The Unified Protocol (UP), is emotion-focused cognitive-behavioral therapy. It consists 5 core treatment modules: (1) mindful emotion awareness, (2) cognitive flexibility, (3) identifying and preventing patterns of emotion avoidance, (4) increasing awareness and tolerance of emotion-related physical sensations, and (5) interoceptive and situational emotion-focused exposures. Its 5 core modules are preceded by a module focused on enhancing motivation and an introductory module on the adaptive nature of emotions that provides a framework for understanding emotional experiences. Participants will receive at least 36 individual sessions weekly (1 hour ).The sessions will follow these modules and will be changed based on individuals’ needs and conditions: Psychoeducation and treatment rationale ; Motivation and goal setting; Mindful emotion awareness; Cognitive reappraisal ; Countering emotional avoidance;  Awareness of physical sensations; and Imaginal and situational emotional exposures. Intervention 2: Intervention 2: Intervention 2: Dyadic-developmental psychotherapy is a form of psychotherapy that can help form and repair connections and attachment between children, young people and their parent/carers. It tries to create a "playful, accepting, curious, and empathic" environment in which the therapist attunes to the child's "subjective experiences" and reflects this back to the child by means of eye contact, facial expressions, gestures and movements, voice tone, timing. The child and parents working together with the therapist. The child gains relationship experience which helps her to grow and heal emotionally. Family members develop healthy patterns of relating and communicating. It consists five steps:  1: Relationship Building; 2: Problem Assessment; 3: Goal Setting; 4: Counselling Intervention, and 5: Evaluation, Termination. It will be applied through 16 weekly session (60-90 minutes).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Demographic information and the results of measures will be available after deidentifying process

When:
When the results will be published, researchers could have access to data due to reasonable requests

To whom:
Data will be available for the mental health researchers

Conditions:
Data will be available for systematic review

Where to obtain:
Please contact Dr. Banafsheh Mohajerin Address: Psychology Department, Taleghani Hospital, Arabi St, Yaman St, velenjak. Tehran
 Tel: 982123031548 
Banafshehmohajerin@gmail.com

How to obtain:
After data will be published, data will be available within one week

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Banafsheh Mohajerin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Taleghani Hoispital, Arabi St, Yaman St, Velenjak</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985711151</zip>
        <telephone>+98 21 2303 1548</telephone>
        <email>banafshehmohajerin@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Banafsheh Mohajerin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Taleghani Hospital,Arabi St, Yaman St, Velenjak</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985711151</zip>
        <telephone>+98 21 2303 1548</telephone>
        <email>banafshehmohajerin@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Meet the diagnostic criteria of  Developmental trauma disorder / or Post-traumatic stress disorder
Aged between 6 and 65
Be able to speak and read Farsi</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>met criteria for a psychotic disorder
met criteria for Bipolar mood disorder
intellectual disability
Required specialized treatment for high risk of suicide
Missing at least three treatment sessions continuously
Primary care giver refuse for participation in this study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F43.1</hc_code>
      <hc_code>F43.10</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Post-traumatic stress disorder (PTSD)</hc_keyword>
      <hc_keyword>Post-traumatic stress disorder, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: The Unified Protocol (UP), is emotion-focused cognitive-behavioral therapy. It consists 5 core treatment modules: (1) mindful emotion awareness, (2) cognitive flexibility, (3) identifying and preventing patterns of emotion avoidance, (4) increasing awareness and tolerance of emotion-related physical sensations, and (5) interoceptive and situational emotion-focused exposures. Its 5 core modules are preceded by a module focused on enhancing motivation and an introductory module on the adaptive nature of emotions that provides a framework for understanding emotional experiences. Participants will receive at least 36 individual sessions weekly (1 hour ).The sessions will follow these modules and will be changed based on individuals’ needs and conditions: Psychoeducation and treatment rationale ; Motivation and goal setting; Mindful emotion awareness; Cognitive reappraisal ; Countering emotional avoidance;  Awareness of physical sensations; and Imaginal and situational emotional exposures</i_keyword>
      <i_keyword>Intervention 2: Intervention 2: Dyadic-developmental psychotherapy is a form of psychotherapy that can help form and repair connections and attachment between children, young people and their parent/carers. It tries to create a "playful, accepting, curious, and empathic" environment in which the therapist attunes to the child's "subjective experiences" and reflects this back to the child by means of eye contact, facial expressions, gestures and movements, voice tone, timing. The child and parents working together with the therapist. The child gains relationship experience which helps her to grow and heal emotionally. Family members develop healthy patterns of relating and communicating. It consists five steps:  1: Relationship Building; 2: Problem Assessment; 3: Goal Setting; 4: Counselling Intervention, and 5: Evaluation, Termination. It will be applied through 16 weekly session (60-90 minutes).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Post-traumatic stress symptoms severity. Timepoint: baseline, after intervention, 6, and 12 months after intervention as a follow-up phas. Method of measurement: by using PTSD Checklist  (PCL-5; Blevins et al., 2015).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Anger severity. Timepoint: baseline, after intervention, 6, and 12 months after intervention as a follow-up phase. Method of measurement: by using self-report the State–Trait Anger Expression Inventory–2 questionnaire.</sec_outcome>
      <sec_outcome>Dissociative symptoms severity. Timepoint: baseline, after intervention, 6, and 12 months after intervention as a follow-up phase. Method of measurement: by using self-report the dissociative Experiences Scale questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-10-12</approval_date>
        <contact_name>Research Ethics Committees of Shahid Behehshti University of Medical Sciences</contact_name>
        <contact_address>Arabi St, Yaman St, Velenjak, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
